Literature DB >> 32723800

Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.

Hanna Ferløv Schwensen1, Line Kristine Borreschmidt2,3, Merete Storgaard4, Søren Redsted5, Steffen Christensen6, Line Bille Madsen2.   

Abstract

There is growing evidence of histopathological changes in autopsied individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, data on histopathological changes in autopsied patients with eradicated COVID-19 are limited. We performed an autopsy on a Caucasian female in her 80s, who died due to severe, bilateral pulmonary fibrosis after eliminated SARS-CoV-2 infection. In addition, CT scans from 2 months before infection and from 6 days prior to death were compared. Comparison of the CT scans showed bilateral development of widespread fibrosis in previously healthy lungs. Microscopic examination showed different areas with acute and organising diffuse alveolar damage and fibrosis with honeycomb-like remodelling and bronchial metaplasia. We here report a unique autopsy case with development of widespread pulmonary fibrosis in a woman in her 80s with previous COVID-19 and no history of pulmonary illnesses. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  fibrosis; infections; lung; pathology; surgical

Year:  2020        PMID: 32723800     DOI: 10.1136/jclinpath-2020-206879

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

1.  Increased frequency of pneumothorax and pneumomediastinum in COVID-19 patients admitted in the ICU: A multicentre study from Mumbai, India.

Authors:  Zarir F Udwadia; Kedar K Toraskar; Lancelot Pinto; Jai Mullerpatan; Haresh D Wagh; Joanne M Mascarenhas; Bhavesh M Gandhi; Awatansh Tripathi; Ayesha Sunavala; Umang Agrawal; Viral Nanda; Nikita Abraham; Bony Francis; Ravindra R Zore; Gurudas Pundpal; Bhoosan Gondse; Gaurav A Gupta
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

Review 2.  Histopathological Findings in COVID-19 Cases: A Systematic Review.

Authors:  Hamed Hammoud; Ahmed Bendari; Tasneem Bendari; Iheb Bougmiza
Journal:  Cureus       Date:  2022-06-01

Review 3.  Post-COVID lung fibrosis: The tsunami that will follow the earthquake.

Authors:  Zarir F Udwadia; Parvaiz A Koul; Luca Richeldi
Journal:  Lung India       Date:  2021-03

Review 4.  Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.

Authors:  Eleni Korompoki; Maria Gavriatopoulou; Rachel S Hicklen; Ioannis Ntanasis-Stathopoulos; Efstathios Kastritis; Despina Fotiou; Kimon Stamatelopoulos; Evangelos Terpos; Anastasia Kotanidou; Carin A Hagberg; Meletios A Dimopoulos; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2021-05-14       Impact factor: 6.072

Review 5.  Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings.

Authors:  Omar H Fahmy; Farah M Daas; Vidyulata Salunkhe; Jessica L Petrey; Ediz F Cosar; Julio Ramirez; Ozan Akca
Journal:  Crit Care Explor       Date:  2021-05-20

6.  COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies.

Authors:  Ashraf Roshdy; Shroque Zaher; Hossam Fayed; John Gerry Coghlan
Journal:  Front Cardiovasc Med       Date:  2021-01-28

Review 7.  Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.

Authors:  Andrii Puzyrenko; Juan C Felix; Yunguang Sun; Hallgeir Rui; Yuri Sheinin
Journal:  Pathol Res Pract       Date:  2021-02-15       Impact factor: 3.309

8.  Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China.

Authors:  Yan Li; Junhua Wu; Sihua Wang; Xiang Li; Junjie Zhou; Bo Huang; Danju Luo; Qin Cao; Yajun Chen; Shuo Chen; Lin Ma; Li Peng; Huaxiong Pan; William D Travis; Xiu Nie
Journal:  Histopathology       Date:  2020-11-11       Impact factor: 5.087

9.  Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

Authors:  Andre De Souza; Fabio A Tavora; Devalingam Mahalingam; Pamela N Munster; Howard P Safran; Wafik S El-Deiry; Benedito A Carneiro
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

10.  Assessment and characterisation of post-COVID-19 manifestations.

Authors:  Marwa Kamal; Marwa Abo Omirah; Amal Hussein; Haitham Saeed
Journal:  Int J Clin Pract       Date:  2020-11-03       Impact factor: 3.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.